Pharma News
M&A activity related to virtual care increased in the pharmaceutical industry in 2023

In value terms, virtual care-related deal activity increased by 7003% in Q1 2023 compared with the previous quarter’s total of $6m. Related deal volume increased by 100% in Q1 2023 versus the previous quarter and was 500% higher than in Q1 2022.
The top-ranked legal advisors supporting these M&A deals in Q1 2023 were Greenberg Traurig; Morrison Foerster; Sheppard, Mullin, Richter & Hampton with 1, 1, 1 deals respectively.
For further understanding of GlobalData’s Telehealth Market Size by Segments, Share, Trends, and Forecast, 2022-2030 buy the report here.
Source link
#activity #related #virtual #care #increased #pharmaceutical #industry